A Novel Definition and Grading Diagnostic Criteria for Tumour‐Type‐Specific Comprehensive Cachexia Risk
Journal of Cachexia, Sarcopenia and Muscle · 2025-04 · 16 (2)
DOI: 10.1002/jcsm.13744 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 21.03.2025. Verfasst von Chunlei Hu und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Hospital of Tsinghua University, Tsinghua University, Beijing, China. Hauptthemen laut MEDLINE: Cachexia, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, Beijing Municipal Science and Technology Commission Program, National Basic Research Program of China.
Abstract (Originalsprache)
Background
The existing diagnostic criteria for cancer cachexia do not meet clinical needs. We aimed to establish novel comprehensive evaluation scales for cachexia specific to patients with solid tumours.
Methods
This study included 12 651 patients (males: 6793 [53.7%]; females: 5858 [46.3%]; medium age: 58 [interquartile range:50/66] years; medium follow‐up duration: 24.16 [13.32/44.84] months; 4271 [33.8%] patients died; mean survival: 55.53 [95% confidence interval, 54.87/56.10] months; 3344 [26.4%], 4184 [33.1%] and 5123 [40.5%] patients with Stage I–II, III and IV tumour, respectively; derivation set: 10022, validation set: 2629 patients) with 14 types of solid tumours, including lung, gastric, liver, breast, oesophageal, cervical, bladder, pancreatic, prostate, ovarian, colorectal cancer, nasopharyngeal and endometrial carcinoma and cholangiocarcinoma, from an open and ongoing multicentre cohort study in China. Risk factors for cachexia, including tumour characteristics and nutritional parameters, were examined to develop diagnostic scales using Cox proportional hazards models and Kaplan–Meier analysis.
Results
Ten nutrition items (body mass index, weight loss, intake reduction, physical activity function, fatigue, handgrip strength, anorexia, albumin level, albumin/globulin ratio and neutrophil/lymphocyte ratio) with different weighted scores were identified to construct a nutrition‐weighted scoring scale (NWSS) for nutrition risk. Tumour type and tumour burden status (tumour‐node‐metastasis stage and radical or non‐radical tumour) were determined to construct a disease‐weighted scoring scale (DWSS) for disease risk. A lumped scale (5 × 5 matrix) established using a five‐grade classification of nutrition and disease risk was used to determine a five‐grade classification of comprehensive cachexia risk: A, no cachexia risk (reference; lowest disease and nutrition risks); B, cachexia risk (hazard ratio [HR] = 4.517 [4.033/5.058]); C, pre‐cachexia (HR = 9.755 [8.73/10.901], medium survival = 21.21 months); D, cachexia (HR = 16.901 [14.995/19.049], medium survival = 11.61 months); and E, refractory cachexia (HR = 31.879 [28.244/35.981], medium survival = 4.83 months, highest disease and nutrition risks) ( p < 0.001). Patients in Categories A–D benefited from nutrition therapy and anti‐tumour treatments to varying degrees. Patients in Category E were clinically refractory to nutrition therapy without prolonged survival compared with patients without nutrition therapy (medium survival, pre‐hospitalization nutrition therapy vs. hospitalization nutrition therapy vs. without nutrition therapy, 2.89 [1.91/3.88] vs. 4.04 [3.21/4.88] vs. 5.89 [4.73/7.04] months, p = 0.015) and anti‐tumour treatments without prolonged survival compared with patients receiving palliative care (medium survival, radical anti‐tumour treatments vs. adjuvant anti‐tumour treatments vs. palliative anti‐tumour treatments vs. and palliative care, 6.48 [4.42/8.53] vs. 6.48 [3.23/9.73] vs. 4.83 [4.22/5.44] vs. 2.70 [1.09/4.30] months, p = 0.263).
Conclusion
We systematically developed a novel definition and grading diagnostic criteria for tumour‐type‐specific comprehensive cancer cachexia risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, The First Hospital of Tsinghua University, Tsinghua University, Beijing, China.
- Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China.
- Comprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Comprehensive Oncology Department, Hebei Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- College of Public Health, Zhengzhou University, Zhengzhou, China.
ORCID-Profile: Hanping Shi
Förderung
- National Key Research and Development Program
- Beijing Municipal Science and Technology Commission Program
- National Basic Research Program of China
Zitieren
APA
Hu, C., Cong, M., Song, C., Xu, H., Guo, Z., Zhou, F., Zhou, L., Weng, M., Rao, B., Deng, L., Yu, K., Chen, Y., Wang, Z., Ruan, G., Yang, M., Liu, C., Cui, J., Li, W., Wang, K., …, & Shi, H. (2025). A Novel Definition and Grading Diagnostic Criteria for Tumour‐Type‐Specific Comprehensive Cachexia Risk. Journal of Cachexia, Sarcopenia and Muscle, 16(2). https://doi.org/10.1002/jcsm.13744
Vancouver
Hu C, Cong M, Song C, Xu H, Guo Z, Zhou F, et al. A Novel Definition and Grading Diagnostic Criteria for Tumour‐Type‐Specific Comprehensive Cachexia Risk. Journal of Cachexia, Sarcopenia and Muscle. 2025;16(2). doi:10.1002/jcsm.13744
BibTeX
@article{Hu2025,
author = {Hu, Chunlei and Cong, Minghua and Song, Chunhua and Xu, Hongxia and Guo, Zengqing and Zhou, Fuxiang and Zhou, Lan and Weng, Min and Rao, Benqiang and Deng, Li and Yu, Kaiying and Chen, Yongbing and Wang, Ziwen and Ruan, Guotian and Yang, Ming and Liu, Chenan and Cui, Jiuwei and Li, Wei and Wang, Kunhua and Li, Zengning and Liu, Ming and Li, Tao and Chen, Junqiang and von Haehling, Stephan and Barazzoni, Rocco and Shi, Hanping},
title = {A Novel Definition and Grading Diagnostic Criteria for Tumour‐Type‐Specific Comprehensive Cachexia Risk},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2025},
volume = {16},
number = {2},
doi = {10.1002/jcsm.13744}
}
EUVIMED